NEVRO CORP's ticker is NVRO and the CUSIP is 64157F103. A total of 197 filers reported holding NEVRO CORP in Q4 2019. The put-call ratio across all filers is 0.51 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $951,000 | +32.5% | 11,066 | -0.1% | 0.04% | +25.7% |
| Q2 2019 | $718,000 | +17.3% | 11,080 | +13.2% | 0.04% | +12.9% |
| Q1 2019 | $612,000 | +73.9% | 9,792 | +8.1% | 0.03% | +55.0% |
| Q4 2018 | $352,000 | -31.5% | 9,057 | +0.5% | 0.02% | -23.1% |
| Q3 2018 | $514,000 | -27.5% | 9,012 | +1.5% | 0.03% | -31.6% |
| Q2 2018 | $709,000 | -6.1% | 8,878 | +1.9% | 0.04% | -9.5% |
| Q1 2018 | $755,000 | +26.5% | 8,716 | +0.8% | 0.04% | +27.3% |
| Q4 2017 | $597,000 | -23.2% | 8,646 | +1.1% | 0.03% | -25.0% |
| Q3 2017 | $777,000 | +24.1% | 8,549 | +1.6% | 0.04% | +18.9% |
| Q2 2017 | $626,000 | – | 8,411 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Consonance Capital Management LP | 1,446,333 | $82,441,000 | 4.44% |
| Asymmetry Capital Management, L.P. | 31,379 | $1,789,000 | 1.65% |
| TIRSCHWELL & LOEWY INC | 194,470 | $11,085,000 | 1.38% |
| ZEVENBERGEN CAPITAL INVESTMENTS LLC | 673,480 | $38,388,000 | 1.22% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 525,040 | $29,927,000 | 1.07% |
| Orbimed Advisors | 1,357,691 | $77,388,000 | 0.93% |
| Sio Capital Management, LLC | 45,091 | $2,570,000 | 0.88% |
| PURA VIDA INVESTMENTS, LLC | 60,000 | $3,420,000 | 0.72% |
| SUMMIT PARTNERS PUBLIC ASSET MANAGEMENT, LLC | 159,800 | $9,109,000 | 0.62% |
| Endurant Capital Management LP | 24,171 | $1,378,000 | 0.61% |